Author Gold, Ralf
-
2019 | Journal Article |
Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
Zella, M.; Metzdorf, J.; Ostendorf, F.; Maass, F.; Muhlack, S.; Gold, R. & Haghikia, A. et al. (2019)
Cells, 8(2) pp. 105. DOI: https://doi.org/10.3390/cells8020105
Details DOI
-
2019 | Journal Article |
Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis
Hoepner, R.; Bagnoud, M.; Pistor, M.; Salmen, A.; Briner, M.; Synn, H. & Schrewe, L. et al. (2019)
Acta Neuropathologica, pp. 1-14. DOI: https://doi.org/10.1007/s00401-019-02018-8
Details DOI PMID PMC
-
2019 | Journal Article |
Brainstem Encephalitis With Low-Titer Acetylcholine Receptor Antibodies Mimicking Myasthenia Gravis
Ayzenberg, I.; Ellrichmann, G.; Schroeder, C.; Tönges, L.; Klasing, A.; Pappa, V. & Brück, W. et al. (2019)
Frontiers in Neurology, 10 art. 829. DOI: https://doi.org/10.3389/fneur.2019.00829
Details DOI PMID PMC
-
2018 | Journal Article
Mitoxantrone treatment in a patient with multiple sclerosis and pattern III lesions
Grüter, T.; Metz, I.; Gahlen, A.; Kneiphof, J.; Stork, L.; Brück, W. & Gold, R. et al. (2018)
Clinical and Experimental Neuroimmunology, 9(3) pp. 169-172. DOI: https://doi.org/10.1111/cen3.12466
Details DOI
-
2016 | Conference Abstract
Central nervous system intrinsic effects of Laquinimod in vivo are not mediated via the aryl hydrocarbon receptor
Brueck, W.; Nessler, S.; Gold, R.; John, G. R.; Hayardeny, L. & Haghikia, A. (2016)
Multiple Sclerosis Journal, 22 pp. 857-858. 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, ENGLAND.
London: Sage Publications Ltd.
Details WoS
-
2016 | Journal Article
Monitoring of blood parameters under course-modified MS therapy. Substance-specific relevance and current recommendations for action
Klotz, L.; Berthele, A.; Brück, W. ; Chan, A.; Flachenecker, P.; Gold, R. & Haghikia, A. et al. (2016)
Der Nervenarzt, 87(6) pp. 645-659. DOI: https://doi.org/10.1007/s00115-016-0077-1
Details DOI PMID PMC WoS
-
2015 | Journal Article |
Glial cells express nuclear nrf2 after fumarate treatment for multiple sclerosis and psoriasis.
Metz, I.; Traffehn, S.; Straßburger-Krogias, K.; Keyvani, K.; Bergmann, M.; Nolte, K. & Weber, M. S. et al. (2015)
Neurology® neuroimmunology & neuroinflammation, 2(3) art. e99. DOI: https://doi.org/10.1212/NXI.0000000000000099
Details DOI PMID PMC
-
2015 | Journal Article |
Progressive multifocal leukoencephalopathy during fumarate monotherapy of psoriasis.
Hoepner, R.; Faissner, S.; Klasing, A.; Schneider, R.; Metz, I.; Bellenberg, B. & Lukas, C. et al. (2015)
Neurology® neuroimmunology & neuroinflammation, 2(3) art. e85. DOI: https://doi.org/10.1212/NXI.0000000000000085
Details DOI PMID PMC
-
2015 | Journal Article
cFLIP overexpression in T cells in thymoma-associated myasthenia gravis
Belharazem, D.; Schalke, B.; Gold, R.; Nix, W.; Vitacolonna, M.; Hohenberger, P. & Roessner, E. et al. (2015)
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2(9) pp. 894-905. DOI: https://doi.org/10.1002/acn3.210
Details DOI PMID PMC WoS
-
2015 | Conference Abstract
Key regulatory function of vitamin D for response to glucocorticosteroids in multiple sclerosis
Hoepner, R.; Pittlik, S. M.; Salmen, A.; Arakrak, F.; Pedreiturria, X.; Gold, R. & Reichardt, H. et al. (2015)
Multiple Sclerosis Journal, 21 pp. 547-548. 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN.
London: Sage Publications Ltd.
Details WoS
-
2015 | Conference Abstract
Increased nuclear Nrf2 expression after fumarate treatment for multiple sclerosis and psoriasis
Metz, I.; Traffehn, S.; Strassburger-Krogias, K.; Keyvani, K.; Bergmann, M.; Nolte, K. & Weber, M. et al. (2015)
Multiple Sclerosis Journal, 21 pp. 259-260. 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, SPAIN.
London: Sage Publications Ltd.
Details WoS
-
2015 | Journal Article
Thymocyte-derived BDNF influences T-cell maturation at the DN3/DN4 transition stage
Linker, R. A.; Lee, D.-H.; Flach, A.-C.; Litke, T. ; van den Brandt, J.; Reichardt, H. M. & Lingner, T. et al. (2015)
European Journal of Immunology, 45(5) pp. 1326-1338. DOI: https://doi.org/10.1002/eji.201444985
Details DOI PMID PMC WoS
-
2015 | Journal Article
Lack of efficacy of mitoxantrone in primary progressive Multiple Sclerosis irrespective of pharmacogenetic factors: A multi-center, retrospective analysis
Grey (nee Cotte), S.; Salmen (nee Stroet), A.; von Ahsen, N.; Starck, M.; Winkelmann, A.; Zettl, U. K. & Comabella, M. et al. (2015)
Journal of Neuroimmunology, 278 pp. 277-279. DOI: https://doi.org/10.1016/j.jneuroim.2014.11.017
Details DOI PMID PMC WoS
-
2015 | Journal Article
Current aspects of therapy conversion for multiple sclerosis
Kolber, P.; Luessi, F.; Meuth, S. G.; Klotz, L.; Korn, T.; Trebst, C. & Tackenberg, B. et al. (2015)
Der Nervenarzt, 86(10) pp. 1236-1247. DOI: https://doi.org/10.1007/s00115-015-4368-8
Details DOI PMID PMC WoS
-
2014 | Journal Article
Late-onset myasthenia gravis – CTLA4low genotype association and low-for-age thymic output of naïve T cells
Chuang, W.-Y.; Ströbel, P.; Bohlender-Willke, A.-L.; Rieckmann, P.; Nix, W.; Schalke, B. & Gold, R. et al. (2014)
Journal of Autoimmunity, 52 pp. 122-129. DOI: https://doi.org/10.1016/j.jaut.2013.12.006
Details DOI
-
2014 | Conference Abstract
Critical role of thymocyte-derived brain-derived neurotrophic factor in T cell maturation
Luehder, F.; Linker, R.; Lee, D.-h.; Reichardt, H. ; Bommhardt, U.; Gold, R. & Fluegel, A. (2014)
Journal of Neuroimmunology, 275(1-2) pp. 202-203. 12th International Congress of Neuroimmunology (ISNI), Mainz, GERMANY.
Amsterdam: Elsevier Science Bv. DOI: https://doi.org/10.1016/j.jneuroim.2014.08.544
Details DOI WoS
-
2014 | Journal Article |
Increase of angiotensin II type 1 receptor auto-antibodies in Huntington's disease
Lee, D.-H.; Heidecke, H.; Schroeder, A.; Paul, F.; Wachter, R. R.; Hoffmann, R. & Ellrichmann, G. et al. (2014)
Molecular Neurodegeneration, 9 art. 49. DOI: https://doi.org/10.1186/1750-1326-9-49
Details DOI PMID PMC WoS
-
2014 | Journal Article | Letter Note
Trial and error in clinical studies: lessons from ATAMS
Luehder, F. & Gold, R. (2014)
The Lancet Neurology, 13(4) pp. 340-341. DOI: https://doi.org/10.1016/S1474-4422(14)70050-X
Details DOI PMID PMC WoS
-
2013 | Review
Therapeutic Decisions in Multiple Sclerosis Moving Beyond Efficacy
Brueck, W.; Gold, R.; Lund, B. T.; Oreja-Guevara, C.; Prat, A.; Spencer, C. M.& Steinman, L. et al. (2013)
JAMA Neurology, 70(10) pp. 1315-1324.
Amer Medical Assoc. DOI: https://doi.org/10.1001/jamaneurol.2013.3510
Details DOI PMID PMC WoS
-
2013 | Review
Brain-Derived Neurotrophic Factor in Neuroimmunology: Lessons Learned from Multiple Sclerosis Patients and Experimental Autoimmune Encephalomyelitis Models
Luehder, F.; Gold, R.; Fluegel, A.& Linker, R. A. (2013)
Archivum Immunologiae et Therapiae Experimentalis, 61(2) pp. 95-105.
Basel: Springer. DOI: https://doi.org/10.1007/s00005-012-0211-0
Details DOI PMID PMC WoS